Sunday, November 24, 2013

08:30-10:00
DIFFERENT WAYS TO EVALUATE AND CONTROL RA
Capsule
Distinct biological effects of targeted therapies may be reflected in different responses, as a consequence, the search for biomarkers and best predictors of reaching remission or LDA is a potential goal. Data published shows that some multi-biomarkers tests performed well in the assessment of disease activity in RA patients. Doctors need to understund whether these new published biomarkers are useful in improving diagnosis, controlling treatments and relapses, and/or preventing either manifestations or risk factors related to the disease. Today, is there really one or a composite group of biomarkers as good at predicting a better outcome?
Chairpersons J.J. Scali, Argentina
S. Gay, Switzerland
Biomarkers in physiopathogenic process
C. Buckley, UK
Are there several biomarkers to prevent risk factors?
Atherosclerosis in rheumatoid arthritis and SLE
A. Doria, Italy
Objectives Upon completion of the session, the audience will have learned:
  • The real value and utility of several biomarkers in detecting disease
  • Side effects and the utility of systemic involvement in understunding how different biomarkers are useful in diagnosing and controlling disease activity
  • How and when to use biomarkers in clinical practice

10:30-12:00
HYDROLYSATE COLLAGEN TO TREAT OA: WHAT’S THE EVIDENCE?
Capsule
Collagen derivatives (hydrolysates) have been proposed as candidates for disease-modification in OA. These derivatives are marketed as having direct chondroprotective action and reducing complaints of OA
Chairpersons M. Marty, France
I. Baert, Belgium
Debate: Are collagen derivatives (hydrolysates) realistic candidates for disease-modification in osteoarthritis?
No: S.M.A. Bierma-Zeinstra, Netherlands
Yes: S. Oesser, Germany
Discussion
What is the place of food supplements in the treatment of OA?
J. Monfort, Spain
Objective To show the evidence for and against symptomatic and chondroprotective treatment with collagen derivatives in patients with OA

08:30-10:00
CONTROVERSIAL ISSUES IN OSTEOPOROSIS AND OSTEOARTHRITIS

Endorsed and organized by the Portuguese Society of Osteoporosis and Other Metabolic Bone Diseases (SPODOM)

Capsule The goal of this symposium is to discuss several controversial issues such as the role of inflammation in the pathophysiology and the bone quality by TBS in the diagnosis of osteoporosis, including Portuguese data and experience. In addition, this session will also discuss implant problems after osteoporotic fracture healing, and finally the Portuguese data in a multicenter study addressing the problem of pain in knee osteoarthritis
Chairpersons A.P. Barbosa, Portugal
P. Coelho, Portugal
Inflammation and Osteoporosis
A. Rodrigues, Portugal
Bone quality by TBS in Portuguese female population
M. Mascarenhas, Portugal
To remove or not to remove implants after fracture healing
J. Monteiro, Portugal
Pain in knee osteoarthritis—the Portuguese experience
J. Lains, Portugal

10:30-12:00
SURGERY OF OA JOINTS
Capsule Cartilage lesion repair of cells by cell/matrix transplantation is a growing domain in orthopaedic surgery. The success of these surgical approaches is dependent on the post-surgical rehabilitation.  Protocols of rehabilitation and guidelines of good practices have been recently formulated by physicians and scientific associations.  What is the impact of the biomaterials, the surgery techniques and rehabilitation on the cartilage quality? This session will try to answer these questions
Chairpersons

M.Briittberg, Sweden

A. Van Ginckel, Belgium

Tribology of total hip replacement
P. Gillet, Belgium
Cartilage adaptations after ACL injury and reconstruction: Implications for clinical management and return to play decisions?
A. Van Ginckel, Belgium
Current trends in surgical repair of cartilage and fibrocartilage in large synovial joints
H. Madry, Germany
Current trends in rehabilitation of cartilage problems
D. Van Assche, Belgium
Objective To provide updated protocals of rehabilitation and to implement recent guidelines for the management of pateints with cartilage lesions after surgery

 

Reduced Registration
Deadline
November 18, 2013
more

 

Keep me updated

KeepMeUpdated2